Goldman Sachs’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-5,367
Closed -$86K – 5587
2019
Q4
$86K Buy
+5,367
New +$77.2K ﹤0.01% 5067

Other funds holding VSTM

Goldman Sachs's VSTM Position: Q3 2026 in Review

Goldman Sachs reduced its Verastem (VSTM) stake by 47% in Q3 2026, selling an estimated $8.57M and leaving 1,443,118 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3087.

Goldman Sachs first reported a position in VSTM in Q2 2013 and has held it in 47 quarters since. 162 funds tracked by Wall St. Rank hold VSTM as of Q3 2026.

  • Goldman Sachs held 1,443,118 shares of Verastem worth $11.6M as of Q3 2026.
  • Goldman Sachs sold 1,278,060 Verastem shares in Q3 2026, an estimated $8.57M.
  • Verastem made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #3087 holding.
  • Goldman Sachs first reported a position in Verastem in Q2 2013 and has held it in 47 quarters since.
  • 162 funds tracked by Wall St. Rank held Verastem as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.